公开(公告)号：US20220005571A1

公开(公告)日：2022-01-06

申请号：US17448134

申请日：2021-09-20

Applicant: OMRON HEALTHCARE Co., Ltd.

Inventor： Hiroshi OGAWA ,  Asa HIRASAWA ,  Tamio UEDA ,  Kensuke IBATA ,  Tomoya ISHIDA ,  Hideyuki KOBAYASHI ,  Mizuki FURUTA

IPC: G16H20/10 ,  A61B5/00 ,  G16H10/60

Abstract: To ensure further accurate management of a status of medication administration, one aspect of the present invention acquires declaration information regarding the medication administration of a user, acquires biological information of the user and causes a storage medium to store the biological information, calculates a degree of dispersion of the biological information acquired in a target period based on the biological information stored in the storage medium, determines reliability of the declaration information regarding the medication administration acquired in the target period based on the degree of dispersion of the biological information, and outputs information representing a determination result of the reliability.

公开(公告)号：US20220005570A1

公开(公告)日：2022-01-06

申请号：US17448115

申请日：2021-09-20

Applicant: OMRON HEALTHCARE CO., LTD.

Inventor： Hiroshi OGAWA ,  Asa HIRASAWA ,  Tamio UEDA ,  Kensuke IBATA ,  Tomoya ISHIDA ,  Hideyuki KOBAYASHI ,  Masaki YAMADA ,  Takanobu YAMAUCHI ,  Mizuki FURUTA

IPC: G16H20/10 ,  G16H70/40 ,  G16H50/70 ,  G16H50/20 ,  G06Q30/02 ,  G16H10/60 ,  A61B5/00

Abstract: The present invention provides prediction information for an effect of taking a medicine on a biometric value. A medication assistance information providing device includes a first acquisition unit configured to acquire prescription information related to a medicine that a user plans to take, a second acquisition unit configured to acquire dosing adherence rate information including a dosing adherence rate representing a medication achievement of the user with respect to a dosage specified by the prescription information, a third acquisition unit configured to acquire change prediction information for a biometric value of the user relative to the dosing adherence rate on the basis of the prescription information and the dosing adherence rate information, and a first provision unit configured to provide the change prediction information for the biometric value.